Cardiome's Mission
To discover, develop and commercialize new therapies that will improve the quality of life and health of patients.
Corporate Strategies
 |
GrowthTo leverage our expertise in ion-channel research to grow our portfolio into new therapeutic areas with unmet medical needs through strategic partnerships and research alliances. |
 |
ValueTo deliver meaningful returns to shareholders by continuing to develop innovative and relevant products that provide value to patients, physicians and healthcare systems around the world. |
 |
PeopleTo invest in and develop highly skilled leaders who embrace and drive change through innovation and collaboration to achieve professional and organizational success. |
Awards
Cardiome received the 2011 Biotech Company of the Year Gold Leaf Award from BioteCanada for advancing a new molecular entity from discovery to commercialization.
Cardiome was listed in BIV as one of BC’s top 100 high tech companies in 2010.
Cardiome was recognized as LifesciencesBC’s Company of the Year in 2010.